CX3CL1 and ovarian serous cystadenocarcinoma: The data indicated that CX3CL1, across a variety of cancer types, was substantially associated with distinct pathological stages, including KICH, KIRC, ovarian serous cystadenocarcinoma (OV), LUSC, STAD, and LIHC.